Abbott Laboratories (WBO:ABT)
€ 108.8 -0.92 (-0.84%) Market Cap: 190.09 Bil Enterprise Value: 197.21 Bil PE Ratio: 34.45 PB Ratio: 4.94 GF Score: 92/100

Q1 2023 Abbott Laboratories Earnings Call Transcript

Apr 19, 2023 / 01:00PM GMT
Release Date Price: €101.72 (+7.07%)
Operator

Good morning, and thank you for standing by. Welcome to Abbott's First Quarter 2023 Earnings Conference Call. (Operator Instructions) This call is being recorded by Abbott. With the exception of any participants' questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is material copyrighted by Abbott. It cannot be recorded or rebroadcast without Abbott's expressed written permission.

I would now like to introduce Mr. Scott Leinenweber, Vice President, Investor Relations, Licensing and Acquisitions.

Scott Michael Leinenweber
Abbott Laboratories - VP of IR, Licensing & Acquisitions

Good morning, and thank you for joining us. With me today are Robert Ford, Chairman and Chief Executive Officer; and Bob Funck, Executive Vice President, Finance and Chief Financial Officer. Robert and Bob will provide opening remarks. Following their comments, we'll take your questions. .

Before we get started, some statements made today may be forward-looking for purposes of the Private Securities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot